Global Cancer Screening Market Size, Status and Forecast 2022
- QYR2352220
- 103 Pages
- January 2018
- Medical Devices
Abbott
Roche
Fujirebio Diagnostics, Inc.
BioMérieux
Beckman Coulter
Clarient
Siemens
DiaSorin
Qiagen
Xeptagen
Orion Genomics.
Hologic, Inc.
Quest Diagnostics
Oncohealth Corporation
Femasys, Inc.
Biohit Oyj
Sysmex
Immunostics
Alere
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Application, Cancer Screening can be split into
Medical
Biology
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Cancer Screening Market Size, Status and Forecast 2022
1 Industry Overview of Cancer Screening
1.1 Cancer Screening Market Overview
1.1.1 Cancer Screening Product Scope
1.1.2 Market Status and Outlook
1.2 Global Cancer Screening Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Cancer Screening Market by End Users/Application
1.3.1 Medical
1.3.2 Biology
1.3.3 Other
2 Global Cancer Screening Competition Analysis by Players
2.1 Cancer Screening Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Abbott
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Cancer Screening Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Roche
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Cancer Screening Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Fujirebio Diagnostics, Inc.
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Cancer Screening Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 BioMérieux
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Cancer Screening Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Beckman Coulter
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Cancer Screening Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Clarient
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Cancer Screening Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Siemens
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Cancer Screening Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 DiaSorin
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Cancer Screening Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Qiagen
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Cancer Screening Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Xeptagen
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Cancer Screening Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Orion Genomics.
3.12 Hologic, Inc.
3.13 Quest Diagnostics
3.14 Oncohealth Corporation
3.15 Femasys, Inc.
3.16 Biohit Oyj
3.17 Sysmex
3.18 Immunostics
3.19 Alere
4 Global Cancer Screening Market Size by Application (2012-2017)
4.1 Global Cancer Screening Market Size by Application (2012-2017)
4.2 Potential Application of Cancer Screening in Future
4.3 Top Consumer/End Users of Cancer Screening
5 United States Cancer Screening Development Status and Outlook
5.1 United States Cancer Screening Market Size (2012-2017)
5.2 United States Cancer Screening Market Size and Market Share by Players (2016 and 2017)
6 EU Cancer Screening Development Status and Outlook
6.1 EU Cancer Screening Market Size (2012-2017)
6.2 EU Cancer Screening Market Size and Market Share by Players (2016 and 2017)
7 Japan Cancer Screening Development Status and Outlook
7.1 Japan Cancer Screening Market Size (2012-2017)
7.2 Japan Cancer Screening Market Size and Market Share by Players (2016 and 2017)
8 China Cancer Screening Development Status and Outlook
8.1 China Cancer Screening Market Size (2012-2017)
8.2 China Cancer Screening Market Size and Market Share by Players (2016 and 2017)
9 India Cancer Screening Development Status and Outlook
9.1 India Cancer Screening Market Size (2012-2017)
9.2 India Cancer Screening Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Cancer Screening Development Status and Outlook
10.1 Southeast Asia Cancer Screening Market Size (2012-2017)
10.2 Southeast Asia Cancer Screening Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions and Application (2017-2022)
11.1 Global Cancer Screening Market Size (Value) by Regions (2017-2022)
11.1.1 United States Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.2 EU Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.3 Japan Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.4 China Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.5 India Cancer Screening Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Cancer Screening Revenue and Growth Rate (2017-2022)
11.2 Global Cancer Screening Market Size (Value) by Application (2017-2022)
11.3 The Market Drivers in Future
12 Cancer Screening Market Dynamics
12.1 Cancer Screening Market Opportunities
12.2 Cancer Screening Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Cancer Screening Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Cancer Screening Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Figure Cancer Screening Product Scope
Figure Global Cancer Screening Market Size (Million USD) (2012-2017)
Table Global Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Screening Market Share by Regions in 2016
Figure United States Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Cancer Screening Market Share by Application in 2016
Table Key Downstream Customer in Medical
Figure Cancer Screening Market Size (Million USD) and Growth Rate in Medical (2012-2017)
Table Key Downstream Customer in Biology
Figure Cancer Screening Market Size (Million USD) and Growth Rate in Biology (2012-2017)
Table Key Downstream Customer in Other
Figure Cancer Screening Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Cancer Screening Market Size (Million USD) by Players (2016 and 2017)
Figure Cancer Screening Market Size Share by Players in 2016
Figure Cancer Screening Market Size Share by Players in 2017
Table Abbott Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Abbott (2012-2017)
Figure Abbott Cancer Screening Business Revenue Market Share in 2016
Table Roche Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Roche (2012-2017)
Figure Roche Cancer Screening Business Revenue Market Share in 2016
Table Fujirebio Diagnostics, Inc. Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Fujirebio Diagnostics, Inc. (2012-2017)
Figure Fujirebio Diagnostics, Inc. Cancer Screening Business Revenue Market Share in 2016
Table BioMérieux Basic Information List
Table Cancer Screening Business Revenue (Million USD) of BioMérieux (2012-2017)
Figure BioMérieux Cancer Screening Business Revenue Market Share in 2016
Table Beckman Coulter Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Beckman Coulter (2012-2017)
Figure Beckman Coulter Cancer Screening Business Revenue Market Share in 2016
Table Clarient Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Clarient (2012-2017)
Figure Clarient Cancer Screening Business Revenue Market Share in 2016
Table Siemens Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Siemens (2012-2017)
Figure Siemens Cancer Screening Business Revenue Market Share in 2016
Table DiaSorin Basic Information List
Table Cancer Screening Business Revenue (Million USD) of DiaSorin (2012-2017)
Figure DiaSorin Cancer Screening Business Revenue Market Share in 2016
Table Qiagen Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Qiagen (2012-2017)
Figure Qiagen Cancer Screening Business Revenue Market Share in 2016
Table Xeptagen Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Xeptagen (2012-2017)
Figure Xeptagen Cancer Screening Business Revenue Market Share in 2016
Table Orion Genomics. Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Orion Genomics. (2012-2017)
Figure Orion Genomics. Cancer Screening Business Revenue Market Share in 2016
Table Hologic, Inc. Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Hologic, Inc. (2012-2017)
Figure Hologic, Inc. Cancer Screening Business Revenue Market Share in 2016
Table Quest Diagnostics Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Quest Diagnostics (2012-2017)
Figure Quest Diagnostics Cancer Screening Business Revenue Market Share in 2016
Table Oncohealth Corporation Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Oncohealth Corporation (2012-2017)
Figure Oncohealth Corporation Cancer Screening Business Revenue Market Share in 2016
Table Femasys, Inc. Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Femasys, Inc. (2012-2017)
Figure Femasys, Inc. Cancer Screening Business Revenue Market Share in 2016
Table Biohit Oyj Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Biohit Oyj (2012-2017)
Figure Biohit Oyj Cancer Screening Business Revenue Market Share in 2016
Table Sysmex Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Sysmex (2012-2017)
Figure Sysmex Cancer Screening Business Revenue Market Share in 2016
Table Immunostics Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Immunostics (2012-2017)
Figure Immunostics Cancer Screening Business Revenue Market Share in 2016
Table Alere Basic Information List
Table Cancer Screening Business Revenue (Million USD) of Alere (2012-2017)
Figure Alere Cancer Screening Business Revenue Market Share in 2016
Table Global Cancer Screening Market Size (Million USD) by Application (2012-2017)
Figure Global Cancer Screening Market Size (Million USD) by Application in 2012
Figure Global Cancer Screening Market Size (Million USD) by Application in 2013
Figure Global Cancer Screening Market Size (Million USD) by Application in 2014
Figure Global Cancer Screening Market Size (Million USD) by Application in 2015
Figure Global Cancer Screening Market Size (Million USD) by Application in 2016
Figure Global Cancer Screening Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Cancer Screening
Figure United States Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Cancer Screening Market Size (Million USD) by Players (2012-2017)
Figure United States Cancer Screening Market Size Share by Players in 2016
Figure United States Cancer Screening Market Size Share by Players in 2017
Figure EU Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Cancer Screening Market Size (Million USD) by Players (2012-2017)
Figure EU Cancer Screening Market Size Share by Players in 2016
Figure EU Cancer Screening Market Size Share by Players in 2017
Figure Japan Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Cancer Screening Market Size (Million USD) by Players (2012-2017)
Figure Japan Cancer Screening Market Size Share by Players in 2016
Figure Japan Cancer Screening Market Size Share by Players in 2017
Figure China Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Cancer Screening Market Size (Million USD) by Players (2012-2017)
Figure China Cancer Screening Market Size Share by Players in 2016
Figure China Cancer Screening Market Size Share by Players in 2017
Figure India Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Cancer Screening Market Size (Million USD) by Players (2012-2017)
Figure India Cancer Screening Market Size Share by Players in 2016
Figure India Cancer Screening Market Size Share by Players in 2017
Figure Southeast Asia Cancer Screening Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Cancer Screening Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Cancer Screening Market Size Share by Players in 2016
Figure Southeast Asia Cancer Screening Market Size Share by Players in 2017
Figure Global Cancer Screening Market Size (Million USD) by Regions (2017-2022)
Table Global Cancer Screening Market Size (Million USD) by Regions (2017-2022)
Figure Global Cancer Screening Market Size Share by Regions in 2017
Figure Global Cancer Screening Market Size Share by Regions in 2022
Figure United States Cancer Screening Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Cancer Screening Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Cancer Screening Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Cancer Screening Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Cancer Screening Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Cancer Screening Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Cancer Screening Market Size (Million USD) by Application (2017-2022)
Figure Global Cancer Screening Market Size (Million USD) by Application in 2017
Figure Global Cancer Screening Market Size (Million USD) by Application in 2022
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
